⚕ GalenOps CRO console
← 704 (USA)

704-1065

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 704 (USA) (Dr. Tanaka) · consented 2013-10-24
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ABDOMINAL DISCOMFORT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-26 (study day 3.0); relationship: REMOTE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 4.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-11-17 (study day 25.0); relationship: REMOTE

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-12-15 (study day 53.0); relationship: REMOTE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-11-17 (study day 25.0); relationship: REMOTE

mild assessed 2026-08-18

Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild MALAISE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-09 (study day 17.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-27 (study day 4.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-24 (study day 62.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.